cMET: a prognostic marker in papillary renal cell carcinoma?
The tyrosine-protein kinase c-Met plays a decisive role in numerous cellular processes, as a proto-oncogene that supports aggressive tumor behavior. It is still unknown whether c-Met could be relevant for prognosis of papillary RCC (pRCC). Specimen collection was a collaboration of the PANZAR consor...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
6 January 2022
|
| In: |
Human pathology
Year: 2022, Jahrgang: 121, Pages: 1-10 |
| ISSN: | 1532-8392 |
| DOI: | 10.1016/j.humpath.2021.12.007 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.humpath.2021.12.007 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S004681772100215X 
|
| Verfasserangaben: | Franziska Erlmeier MD, Benedict Bruecher MD, Christine Stöhr PhD, Edwin Herrmann Prof, Iris Polifka MD, Abbas Agaimy Prof, Lutz Trojan Prof, Philipp Ströbel MD, Frank Becker MD, Christian Wülfing Prof, Peter Barth MD, Michael Stöckle Prof, Michael Staehler Prof, Christian Stief Prof, Axel Haferkamp Prof, Markus Hohenfellner Prof, Stephan Macher-Göppinger Prof, Bernd Wullich Prof, Joachim Noldus Prof, Walburgis Brenner MD, Frederik C. Roos Prof, Bernhard Walter MD, Wolfgang Otto Prof, Maximilian Burger Prof, Andres Jan Schrader Prof, Arndt Hartmann Prof, Yvonne Mondorf MD, Philipp Ivanyi MD, Marie Mikuteit MD, Sandra Steffens Prof, German Network Of Kidney Cancer |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1795745274 | ||
| 003 | DE-627 | ||
| 005 | 20240416193216.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220316s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.humpath.2021.12.007 |2 doi | |
| 035 | |a (DE-627)1795745274 | ||
| 035 | |a (DE-599)KXP1795745274 | ||
| 035 | |a (OCoLC)1341446137 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Erlmeier, Franziska |d 1985- |e VerfasserIn |0 (DE-588)107067804X |0 (DE-627)824446550 |0 (DE-576)432206434 |4 aut | |
| 245 | 1 | 0 | |a cMET |b a prognostic marker in papillary renal cell carcinoma? |c Franziska Erlmeier MD, Benedict Bruecher MD, Christine Stöhr PhD, Edwin Herrmann Prof, Iris Polifka MD, Abbas Agaimy Prof, Lutz Trojan Prof, Philipp Ströbel MD, Frank Becker MD, Christian Wülfing Prof, Peter Barth MD, Michael Stöckle Prof, Michael Staehler Prof, Christian Stief Prof, Axel Haferkamp Prof, Markus Hohenfellner Prof, Stephan Macher-Göppinger Prof, Bernd Wullich Prof, Joachim Noldus Prof, Walburgis Brenner MD, Frederik C. Roos Prof, Bernhard Walter MD, Wolfgang Otto Prof, Maximilian Burger Prof, Andres Jan Schrader Prof, Arndt Hartmann Prof, Yvonne Mondorf MD, Philipp Ivanyi MD, Marie Mikuteit MD, Sandra Steffens Prof, German Network Of Kidney Cancer |
| 264 | 1 | |c 6 January 2022 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 16.03.2022 | ||
| 520 | |a The tyrosine-protein kinase c-Met plays a decisive role in numerous cellular processes, as a proto-oncogene that supports aggressive tumor behavior. It is still unknown whether c-Met could be relevant for prognosis of papillary RCC (pRCC). Specimen collection was a collaboration of the PANZAR consortium. Patients' medical history and tumor specimens were collected from 197 and 110 patients with type 1 and 2 pRCC, respectively. Expression of cMET was determined by immunohistochemistry. In total, cMET staining was evaluable in of 97 of 197 type 1 and 63 of 110 type 2 pRCC cases. Five-year overall survival revealed no significant difference in dependence of cMET positivity (cMET− vs. cMET+: pRCC type 1: 84.8% vs. 80.3%, respectively [p = 0.303, log-rank]; type 2: 71.4% vs. 64.4%, respectively [p = 0.239, log-rank]). Interestingly, the subgroup analyses showed a significant difference for cMET expression in T stage and metastases of the pRCC type 2 (p = 0.014, p = 0.022, chi-square). The cMET-positive type 2 collective developed more metastases than the cMET-negative cohort (pRCC type 2 M+: cMET−: 2 [4.3%] vs. cMET+: 12 [19%]). cMET expression did not qualify as a prognostic marker in pRCC for overall survival. | ||
| 650 | 4 | |a cMET | |
| 650 | 4 | |a Outcome | |
| 650 | 4 | |a Papillary renal cell carcinoma | |
| 650 | 4 | |a Prognosis | |
| 650 | 4 | |a Survival | |
| 700 | 1 | |a Bruecher, Benedict |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stöhr, Christine |d 1963- |e VerfasserIn |0 (DE-588)17274122X |0 (DE-627)697672859 |0 (DE-576)133598462 |4 aut | |
| 700 | 1 | |a Herrmann, Edwin |d 1977- |e VerfasserIn |0 (DE-588)129095117 |0 (DE-627)389527521 |0 (DE-576)297490907 |4 aut | |
| 700 | 1 | |a Polifka, Iris |e VerfasserIn |0 (DE-588)1197251707 |0 (DE-627)1679033573 |4 aut | |
| 700 | 1 | |a Agaimy, Abbas |d 1966- |e VerfasserIn |0 (DE-588)132505193 |0 (DE-627)523321848 |0 (DE-576)299188728 |4 aut | |
| 700 | 1 | |a Trojan, Lutz |d 1973- |e VerfasserIn |0 (DE-588)124059856 |0 (DE-627)706523571 |0 (DE-576)294001492 |4 aut | |
| 700 | 1 | |a Ströbel, Philipp |d 1969- |e VerfasserIn |0 (DE-588)115588272 |0 (DE-627)077346734 |0 (DE-576)289964784 |4 aut | |
| 700 | 1 | |a Becker, Frank |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wülfing, Christian |e VerfasserIn |0 (DE-588)1114092088 |0 (DE-627)868035173 |0 (DE-576)477209084 |4 aut | |
| 700 | 1 | |a Barth, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stöckle, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Staehler, Michael |d 1969- |e VerfasserIn |0 (DE-588)121812839 |0 (DE-627)081551452 |0 (DE-576)292898118 |4 aut | |
| 700 | 1 | |a Stief, Christian Georg |d 1958- |e VerfasserIn |0 (DE-588)133306364 |0 (DE-627)539965219 |0 (DE-576)299760987 |4 aut | |
| 700 | 1 | |a Haferkamp, Axel |d 1968- |e VerfasserIn |0 (DE-588)102239083X |0 (DE-627)716962608 |0 (DE-576)176465944 |4 aut | |
| 700 | 1 | |a Hohenfellner, Markus |d 1958- |e VerfasserIn |0 (DE-588)133862518 |0 (DE-627)557857988 |0 (DE-576)300155263 |4 aut | |
| 700 | 1 | |a Macher-Göppinger, Stephan |e VerfasserIn |0 (DE-588)1022394061 |0 (DE-627)716963299 |0 (DE-576)365275034 |4 aut | |
| 700 | 1 | |a Wullich, Bernd |d 1960- |e VerfasserIn |0 (DE-588)110835794 |0 (DE-627)691096716 |0 (DE-576)302885749 |4 aut | |
| 700 | 1 | |a Noldus, Joachim |e VerfasserIn |4 aut | |
| 700 | 1 | |a Brenner, Walburgis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Roos, Frederik C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Walter, Bernhard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Otto, Wolfgang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Burger, Maximilian |e VerfasserIn |0 (DE-588)1143130588 |0 (DE-627)1002502772 |0 (DE-576)494921404 |4 aut | |
| 700 | 1 | |a Schrader, Andres Jan |d 1973- |e VerfasserIn |0 (DE-588)121490416 |0 (DE-627)081341644 |0 (DE-576)292736886 |4 aut | |
| 700 | 1 | |a Hartmann, Arndt |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mondorf, Yvonne |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ivanyi, Philipp |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mikuteit, Marie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Steffens, Sandra |d 1980- |e VerfasserIn |0 (DE-588)141318724 |0 (DE-627)626386195 |0 (DE-576)323304907 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Human pathology |d New York, NY [u.a.] : Elsevier, 1970 |g 121(2022), Seite 1-10 |h Online-Ressource |w (DE-627)326644784 |w (DE-600)2041481-X |w (DE-576)094477272 |x 1532-8392 |7 nnas |a cMET a prognostic marker in papillary renal cell carcinoma? |
| 773 | 1 | 8 | |g volume:121 |g year:2022 |g pages:1-10 |g extent:10 |a cMET a prognostic marker in papillary renal cell carcinoma? |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.humpath.2021.12.007 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S004681772100215X |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220316 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 133862518 |a Hohenfellner, Markus |m 133862518:Hohenfellner, Markus |d 910000 |d 910200 |e 910000PH133862518 |e 910200PH133862518 |k 0/910000/ |k 1/910000/910200/ |p 16 | ||
| 998 | |g 102239083X |a Haferkamp, Axel |m 102239083X:Haferkamp, Axel |p 15 | ||
| 999 | |a KXP-PPN1795745274 |e 4090994772 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"6 January 2022"}],"id":{"eki":["1795745274"],"doi":["10.1016/j.humpath.2021.12.007"]},"recId":"1795745274","name":{"displayForm":["Franziska Erlmeier MD, Benedict Bruecher MD, Christine Stöhr PhD, Edwin Herrmann Prof, Iris Polifka MD, Abbas Agaimy Prof, Lutz Trojan Prof, Philipp Ströbel MD, Frank Becker MD, Christian Wülfing Prof, Peter Barth MD, Michael Stöckle Prof, Michael Staehler Prof, Christian Stief Prof, Axel Haferkamp Prof, Markus Hohenfellner Prof, Stephan Macher-Göppinger Prof, Bernd Wullich Prof, Joachim Noldus Prof, Walburgis Brenner MD, Frederik C. Roos Prof, Bernhard Walter MD, Wolfgang Otto Prof, Maximilian Burger Prof, Andres Jan Schrader Prof, Arndt Hartmann Prof, Yvonne Mondorf MD, Philipp Ivanyi MD, Marie Mikuteit MD, Sandra Steffens Prof, German Network Of Kidney Cancer"]},"title":[{"title_sort":"cMET","subtitle":"a prognostic marker in papillary renal cell carcinoma?","title":"cMET"}],"person":[{"display":"Erlmeier, Franziska","family":"Erlmeier","role":"aut","given":"Franziska"},{"display":"Bruecher, Benedict","family":"Bruecher","given":"Benedict","role":"aut"},{"family":"Stöhr","role":"aut","given":"Christine","display":"Stöhr, Christine"},{"display":"Herrmann, Edwin","role":"aut","given":"Edwin","family":"Herrmann"},{"family":"Polifka","given":"Iris","role":"aut","display":"Polifka, Iris"},{"display":"Agaimy, Abbas","family":"Agaimy","role":"aut","given":"Abbas"},{"role":"aut","given":"Lutz","family":"Trojan","display":"Trojan, Lutz"},{"display":"Ströbel, Philipp","role":"aut","given":"Philipp","family":"Ströbel"},{"family":"Becker","role":"aut","given":"Frank","display":"Becker, Frank"},{"role":"aut","given":"Christian","family":"Wülfing","display":"Wülfing, Christian"},{"role":"aut","given":"Peter","family":"Barth","display":"Barth, Peter"},{"display":"Stöckle, Michael","family":"Stöckle","role":"aut","given":"Michael"},{"family":"Staehler","role":"aut","given":"Michael","display":"Staehler, Michael"},{"role":"aut","given":"Christian Georg","family":"Stief","display":"Stief, Christian Georg"},{"family":"Haferkamp","role":"aut","given":"Axel","display":"Haferkamp, Axel"},{"display":"Hohenfellner, Markus","given":"Markus","role":"aut","family":"Hohenfellner"},{"display":"Macher-Göppinger, Stephan","family":"Macher-Göppinger","role":"aut","given":"Stephan"},{"display":"Wullich, Bernd","given":"Bernd","role":"aut","family":"Wullich"},{"family":"Noldus","given":"Joachim","role":"aut","display":"Noldus, Joachim"},{"display":"Brenner, Walburgis","given":"Walburgis","role":"aut","family":"Brenner"},{"display":"Roos, Frederik C.","given":"Frederik C.","role":"aut","family":"Roos"},{"display":"Walter, Bernhard","role":"aut","given":"Bernhard","family":"Walter"},{"family":"Otto","role":"aut","given":"Wolfgang","display":"Otto, Wolfgang"},{"family":"Burger","given":"Maximilian","role":"aut","display":"Burger, Maximilian"},{"display":"Schrader, Andres Jan","family":"Schrader","role":"aut","given":"Andres Jan"},{"display":"Hartmann, Arndt","given":"Arndt","role":"aut","family":"Hartmann"},{"display":"Mondorf, Yvonne","family":"Mondorf","role":"aut","given":"Yvonne"},{"family":"Ivanyi","given":"Philipp","role":"aut","display":"Ivanyi, Philipp"},{"given":"Marie","role":"aut","family":"Mikuteit","display":"Mikuteit, Marie"},{"display":"Steffens, Sandra","given":"Sandra","role":"aut","family":"Steffens"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"10 S."}],"language":["eng"],"relHost":[{"origin":[{"publisherPlace":"New York, NY [u.a.]","dateIssuedDisp":"1970-","dateIssuedKey":"1970","publisher":"Elsevier"}],"id":{"eki":["326644784"],"zdb":["2041481-X"],"issn":["1532-8392"]},"part":{"text":"121(2022), Seite 1-10","extent":"10","pages":"1-10","volume":"121","year":"2022"},"recId":"326644784","disp":"cMET a prognostic marker in papillary renal cell carcinoma?Human pathology","title":[{"title":"Human pathology","title_sort":"Human pathology"}],"note":["Gesehen am 21.07.25"],"type":{"media":"Online-Ressource","bibl":"periodical"},"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.1970 -"],"language":["eng"]}],"note":["Gesehen am 16.03.2022"]} | ||
| SRT | |a ERLMEIERFRCMET6202 | ||